Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cyanocobalamin + pyridoxine
- Development stage
- Unknown
- Lead developer
- Gramón Bagó
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
B-GAN (also marketed as B-GAN 1000) is a dietary supplement developed by Gramón Bagó. It is formulated as dispersible, scored tablets containing 1000 mcg of vitamin B12 (cyanocobalamin) and 0.70 mg of vitamin B6 (pyridoxine hydrochloride). The supplement is designed to support energy metabolism, nervous system function, and immune health, particularly in individuals with dietary deficiencies, such as vegans, vegetarians, older adults, or patients who have undergone gastric surgery.
- Brand names
- B-GANB-GAN 1000B-GAN1000B-GAN-1000
- Other names
- cyanocobalamin + pyridoxine hydrochloridevitamin B12 + vitamin B6vitamina B12 + vitamina B6
02
Targets
DDC (Aromatic L-amino acid decarboxylase)MTR (Methionine synthase)MMUT (Methylmalonyl-coenzyme A mutase)PDXK (Pyridoxal kinase)
Beyond the preview
Go deeper on cyanocobalamin + pyridoxine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cyanocobalamin + pyridoxine.